Rhythm Pharmaceuticals, Inc. Common Stock (RYTM) Financials
Key financial figures for Rhythm Pharmaceuticals, Inc. Common Stock (Q1 2026).
- Revenue
- $60M
- Net Income
- -$56M
- EPS
- $-0.83
- Total Assets
- $442M
- Operating Cash Flow
- -$44M
Full income statement, balance sheet, and cash flow for Rhythm Pharmaceuticals, Inc. Common Stock on SentiSense.